PMID- 38375425 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240417 IS - 2312-0541 (Print) IS - 2312-0541 (Electronic) IS - 2312-0541 (Linking) VI - 10 IP - 1 DP - 2024 Jan TI - Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. LID - 00553-2023 [pii] LID - 10.1183/23120541.00553-2023 [doi] AB - INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the pathogenesis of IPF, and a prior association of the HLA-DQB1 gene with idiopathic fibrotic interstitial pneumonia (including IPF) has been reported. Owing to the important role that the human leukocyte antigen (HLA) region plays in the immune response, here we evaluated if HLA genetic variation was associated specifically with IPF risk. METHODS: We performed a meta-analysis of associations of the HLA region with IPF risk in individuals of European ancestry from seven independent case-control studies of IPF (comprising 5159 cases and 27 459 controls, including a prior study of fibrotic interstitial pneumonia). Single nucleotide polymorphisms, classical HLA alleles and amino acids were analysed and signals meeting a region-wide association threshold of p<4.5x10(-4) and a posterior probability of replication >90% were considered significant. We sought to replicate the previously reported HLA-DQB1 association in the subset of studies independent of the original report. RESULTS: The meta-analysis of all seven studies identified four significant independent single nucleotide polymorphisms associated with IPF risk. However, none met the posterior probability for replication criterion. The HLA-DQB1 association was not replicated in the independent IPF studies. CONCLUSION: Variation in the HLA region was not consistently associated with risk in studies of IPF. However, this does not preclude the possibility that other genomic regions linked to the immune response may be involved in the aetiology of IPF. CI - Copyright (c)The authors 2024. FAU - Guillen-Guio, Beatriz AU - Guillen-Guio B AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. AD - Joint first authors. FAU - Paynton, Megan L AU - Paynton ML AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - Joint first authors. FAU - Allen, Richard J AU - Allen RJ AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. FAU - Chin, Daniel P W AU - Chin DPW AUID- ORCID: 0000-0002-7349-895X AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. FAU - Donoghue, Lauren J AU - Donoghue LJ AD - Genentech, San Francisco, CA, USA. FAU - Stockwell, Amy AU - Stockwell A AD - Genentech, San Francisco, CA, USA. FAU - Leavy, Olivia C AU - Leavy OC AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. FAU - Hernandez-Beeftink, Tamara AU - Hernandez-Beeftink T AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. FAU - Reynolds, Carl AU - Reynolds C AUID- ORCID: 0000-0002-7415-258X AD - National Heart & Lung Institute, Imperial College London, London, UK. FAU - Cullinan, Paul AU - Cullinan P AD - National Heart & Lung Institute, Imperial College London, London, UK. FAU - Martinez, Fernando AU - Martinez F AD - Department of Medicine, Weill Cornell Medicine, New York, NY, USA. FAU - Booth, Helen L AU - Booth HL AD - University College Hospital, University College London, London, UK. FAU - Fahy, William A AU - Fahy WA AD - GlaxoSmithKline, London, UK. FAU - Hall, Ian P AU - Hall IP AD - School of Medicine, University of Nottingham, Nottingham, UK. AD - National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK. FAU - Hart, Simon P AU - Hart SP AUID- ORCID: 0000-0003-4606-9559 AD - Hull York Medical School, University of Hull, Hull, UK. FAU - Hill, Mike R AU - Hill MR AD - MRC Population Health Unit, University of Oxford, Oxford, UK. FAU - Hirani, Nik AU - Hirani N AD - Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK. FAU - Hubbard, Richard B AU - Hubbard RB AD - School of Medicine, University of Nottingham, Nottingham, UK. AD - National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK. FAU - McAnulty, Robin J AU - McAnulty RJ AD - Division of Medicine, University College London, London, UK. FAU - Millar, Ann B AU - Millar AB AD - Bristol Medical School, University of Bristol, Bristol, UK. FAU - Navaratnam, Vidya AU - Navaratnam V AD - Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. AD - National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK. AD - Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia. FAU - Oballa, Eunice AU - Oballa E AD - GlaxoSmithKline, London, UK. FAU - Parfrey, Helen AU - Parfrey H AUID- ORCID: 0000-0002-4515-5634 AD - Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK. FAU - Saini, Gauri AU - Saini G AD - School of Medicine, University of Nottingham, Nottingham, UK. FAU - Sayers, Ian AU - Sayers I AD - Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK. FAU - Tobin, Martin D AU - Tobin MD AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. FAU - Whyte, Moira K B AU - Whyte MKB AD - Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK. FAU - Adegunsoye, Ayodeji AU - Adegunsoye A AD - Department of Medicine, University of Chicago, Chicago, IL, USA. FAU - Kaminski, Naftali AU - Kaminski N AUID- ORCID: 0000-0001-5917-4601 AD - Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA. FAU - Ma, Shwu-Fan AU - Ma SF AD - Department of Medicine, University of Virginia, Charlottesville, VA, USA. FAU - Strek, Mary E AU - Strek ME AD - Department of Medicine, University of Chicago, Chicago, IL, USA. FAU - Zhang, Yingze AU - Zhang Y AUID- ORCID: 0000-0001-6947-2901 AD - Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA. FAU - Fingerlin, Tasha E AU - Fingerlin TE AD - Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, USA. FAU - Molina-Molina, Maria AU - Molina-Molina M AD - Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigacion Biomedica de Bellvitge (IDIBELL), Barcelona, Spain. AD - Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain. AD - Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. FAU - Neighbors, Margaret AU - Neighbors M AD - Genentech, San Francisco, CA, USA. FAU - Sheng, X Rebecca AU - Sheng XR AD - Genentech, San Francisco, CA, USA. FAU - Oldham, Justin M AU - Oldham JM AD - Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA. FAU - Maher, Toby M AU - Maher TM AD - National Heart and Lung Institute, Imperial College London, London, UK. AD - Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, USA. FAU - Molyneaux, Philip L AU - Molyneaux PL AUID- ORCID: 0000-0003-1301-8800 AD - National Heart and Lung Institute, Imperial College London, London, UK. AD - Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK. FAU - Flores, Carlos AU - Flores C AD - Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. AD - Research Unit, Hospital Universitario Nuestra Senora de Candelaria, Santa Cruz de Tenerife, Spain. AD - Genomics Division, Instituto Tecnologico y de Energias Renovables, Santa Cruz de Tenerife, Spain. AD - Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain. FAU - Noth, Imre AU - Noth I AD - Department of Medicine, University of Virginia, Charlottesville, VA, USA. FAU - Schwartz, David A AU - Schwartz DA AD - Department of Medicine, University of Colorado, Anscuhtz, CO, USA. FAU - Yaspan, Brian L AU - Yaspan BL AUID- ORCID: 0000-0002-3787-2510 AD - Genentech, San Francisco, CA, USA. FAU - Jenkins, R Gisli AU - Jenkins RG AD - National Heart and Lung Institute, Imperial College London, London, UK. FAU - Wain, Louise V AU - Wain LV AD - Department of Population Health Sciences, University of Leicester, Leicester, UK. AD - NIHR Leicester Biomedical Research Centre, Leicester, UK. AD - Joint senior authors. FAU - Hollox, Edward J AU - Hollox EJ AUID- ORCID: 0000-0002-0115-2298 AD - Department of Genetics and Genome Biology, University of Leicester, Leicester, UK. AD - Joint senior authors. LA - eng GR - UL1 TR001863/TR/NCATS NIH HHS/United States GR - R56 HL158935/HL/NHLBI NIH HHS/United States GR - WT_/Wellcome Trust/United Kingdom GR - CDA 13-017/HX/HSRD VA/United States GR - R01 HL169166/HL/NHLBI NIH HHS/United States GR - P01 HL162607/HL/NHLBI NIH HHS/United States GR - K23 HL138190/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20240219 PL - England TA - ERJ Open Res JT - ERJ open research JID - 101671641 UOF - medRxiv. 2023 Jul 24;:. PMID: 37546732 PMC - PMC10875457 COIS- Conflict of interest: L.J. Donoghue, A. Stockwell, M. Neighbours, X.R. Sheng and B.L. Yaspan are full-time employees of Genentech; A. Stockwell, M. Neighbours, X.R. Sheng and B.L. Yaspan hold stock options in Roche. J.M. Oldham reports personal fees from Boehringer Ingelheim, Genentech, United Therapeutics, AmMax Bio and Lupin Pharmaceuticals outside the submitted work. D.A. Schwartz is the founder and chief scientific officer of Eleven P15, a company focused on the early detection and treatment of pulmonary fibrosis. R.G. Jenkins reports honoraria from Chiesi, Roche, PatientMPower, AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim, and consulting fees from Bristol Myers Squibb, Daewoong, Veracyte, Resolution Therapeutics, RedX, Pliant and Chiesi. L.V. Wain reports research funding from GlaxoSmithKline, Roche and Orion Pharma, and consultancy for GlaxoSmithKline and Galapagos, outside of the submitted work. S.P. Hart and P.L. Molyneaux are associate editors of this journal. The other authors declare no competing interests. EDAT- 2024/02/20 11:50 MHDA- 2024/02/20 11:51 PMCR- 2024/02/19 CRDT- 2024/02/20 03:45 PHST- 2023/08/01 00:00 [received] PHST- 2023/11/05 00:00 [accepted] PHST- 2024/02/20 11:51 [medline] PHST- 2024/02/20 11:50 [pubmed] PHST- 2024/02/20 03:45 [entrez] PHST- 2024/02/19 00:00 [pmc-release] AID - 00553-2023 [pii] AID - 10.1183/23120541.00553-2023 [doi] PST - epublish SO - ERJ Open Res. 2024 Feb 19;10(1):00553-2023. doi: 10.1183/23120541.00553-2023. eCollection 2024 Jan.